Search for Clinical Trial Results
Mastocytosis, Systemic - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Evaluation of Response of Dasatinib to Treat Mastocytosis Condition: Systemic Mastocytosis Date: 2009-09-16 Interventions: Drug: Dasatinib Starting dosage 20mg once daily, that can be escalated up to 100mg once daily. Patient w |
Recruiting |
Study Name: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 Condition: Indolent Systemic Mastocytosis Date: 2016-06-16 Interventions: Drug: AK002 |
Recruiting |
Study Name: Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia Condition:
Interventions: Drug: brentuximab vedotin Brentuximab vedotin is an antibody with a covalently attached toxin. The antib |
Completed |
Study Name: Patient-Reported Outcome Questionnaire for Systemic Mastocytosis Condition:
|
Recruiting |
Study Name: Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies Condition:
|
Active, not recruiting |
Study Name: Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia Condition:
Interventions: Drug: Midostaurin Midostaurin is a broad-spectrum protein kinase inhibitor, acting on conventional PKC i |
Completed |
Study Name: Stem Cell Transplantation to Treat Systemic Mastocytosis Condition: Mastocytosis Date: 2000-10-17 Interventions: Procedure: Stem cell transplantation |
Recruiting |
Study Name: SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia) Condition:
|
Recruiting |
Study Name: Study of Mast Cell Precursors Condition:
Date: 1999-11-03 |
Completed |
Study Name: Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals Condition:
Date: 1999-11-03 |